. Прогностичка синергија класичних цитокина (IL-6, IL-1β, TNF-α, TGF-β) и нових биомаркера (галектин-3, FGF-23) у предвиђању бубрежних и кардиоваскуларних исхода код пацијената са хроничном болешћу бубрега стадијума 3-4: Цитокини и партнерски биомаркери у прогнози хроничне болести бубрега (ХББ)
Scindeks Asistent Scindeks Asistent — Sistem za uređivanje časopisa
PDF (engleski)

Kako citirati

1.
Zhai W, Guo S. . Прогностичка синергија класичних цитокина (IL-6, IL-1β, TNF-α, TGF-β) и нових биомаркера (галектин-3, FGF-23) у предвиђању бубрежних и кардиоваскуларних исхода код пацијената са хроничном болешћу бубрега стадијума 3-4: Цитокини и партнерски биомаркери у прогнози хроничне болести бубрега (ХББ). J Med Biochem [Internet]. 05. Juni 2026. [citirano 12. Juli 2026.];. Dostupno na: https://asistent.ceon.rs/index.php/jomb/article/view/63275

Sažetak

-

Ključne reči

-
DOI: 10.5937/jomb0-63275

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.